Dr. Paul Ross Senter, MD

Dr. Senter practices at Fort Worth Endoscopy Center in Fort Worth, Texas.

Dr. Senter's NPI, 1841258977, was assigned on May 1, 2006. Dr. Senter graduated from Joe R. & Teresa Lozano Long School of Medicine in 1982. Dr. Senter's Texas license number on file is G3777.

Dr. Senter's primary practice is Fort Worth Endoscopy Center, at 900 West Magnolia Avenue Suite 101, Fort Worth, TX 76104. The practice phone is (817) 332-6500.

Dr. Senter's primary practice is Fort Worth Endoscopy Center in Fort Worth, Texas. Dr. Senter is also affiliated with Texas Health Fort Worth. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Senter to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Senter practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Senter's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Senter is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dr. Senter has a license on file in Texas.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Senter treats.

CMS data shows 472 Medicare services from Dr. Senter across 10 procedure codes in 2024, for 380 Medicare patients. Medicare paid $59,674 for them.

CMS counts 380 Medicare patients who saw Dr. Senter in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Senter's median patient age at 69, with 53% women.

In 2024, Dr. Senter wrote 563 Medicare Part D claims for 435 patients. 71% of them were for generic drugs. CMS names the drug for 491 of them, across 8 drugs with 11 or more claims each, at $25,538 in total drug cost. In 2023, CMS named 464 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Senter for performance year 2024, reported through an alternative payment model (APM). Dr. Senter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 102 procedures of colonoscopy by Dr. Senter, more than 80% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 44 general payments to Dr. Senter from 9 drug and device companies from 2016 to 2024. Education make up the largest share, 71% of the total. Intuitive Surgical, Inc. paid the most, $21,198.

Dmand AI lists 3 awards for Dr. Senter, most recently CMS Stage 1 EHR in 2012.

Dr. Senter graduated from Joe R. & Teresa Lozano Long School of Medicine in 1982. Dr. Senter is a member of ACS and ASCRS.

Dr. Senter is in network with 22 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.